Engineered therapeutic antibodies with enhanced effector functions: Clinical application of the Potelligent® Technology
Korean J Hematol
.
2011 Sep;46(3):148-50.
doi: 10.5045/kjh.2011.46.3.148.
Epub 2011 Sep 30.
Author
Takefumi Matsushita
1
Affiliation
1
Department of Clinical Development, Kyowa Hakko Kirin Co., Ltd., Tokyo, Japan.
PMID:
22065966
PMCID:
PMC3208194
DOI:
10.5045/kjh.2011.46.3.148
No abstract available